---
title: "Lawsuit Claiming Teen’s Death Tied to Faulty AED Equipment on American Airlines Flight Can Move Forward"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286795781.md"
description: "A federal appellate court has allowed a lawsuit to proceed regarding the death of a 14-year-old on an American Airlines flight, linked to a malfunctioning automated external defibrillator (AED). The court found unresolved questions about the AED's functionality during the emergency. The case will return to a Fort Worth federal court for trial, following the family's claims that the flight crew struggled to operate the AED, which failed to deliver a necessary shock."
datetime: "2026-05-18T15:48:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286795781.md)
  - [en](https://longbridge.com/en/news/286795781.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286795781.md)
---

# Lawsuit Claiming Teen’s Death Tied to Faulty AED Equipment on American Airlines Flight Can Move Forward

**Lawsuit Claiming Teen’s Death Tied to Faulty AED Equipment on American Airlines Flight Can Move Forward**

_Court finds ‘a genuine dispute remains’ whether defibrillator functioned during emergency_

A federal appellate court has found that reasonable questions remain about whether an onboard automated external defibrillator functioned properly during the inflight medical treatment of a 14-year-old American Airlines passenger who died inflight. The ruling by a Fifth Circuit panel returns the case to a Fort Worth federal court for trial.

Kevin Greenidge was returning to New York from a summer vacation in Honduras with his family in 2022 when he lost consciousness and became unresponsive shortly after takeoff.

The flight made an emergency landing in Cancun, and Kevin was transported to an area hospital where he was pronounced dead. According to the lawsuit filed by his mother, Melissa Arzu, the flight crew struggled to operate the AED, which failed to deliver an electrical shock to restore Kevin’s heart rhythm.

“As the appellate court noted, the doctor and nurse attending to Kevin during the emergency, together with other witnesses, agreed that no shock occurred,” says Darren Nicholson, one of the attorneys representing Ms. Arzu.

“We are pleased that Kevin’s case will now move forward, nearly four years after his death,” says Hannah Crowe, Ms. Arzu’s other attorney.

Ms. Arzu originally filed her lawsuit in 2022 in New York where she resides, but the airline fought to transfer the case to Fort Worth, where it is headquartered.

Mr. Nicholson and Ms. Crowe, with the law firm of Burns Charest LLP, were retained following the change of venue.

Defibrillators have been federally required on all passenger aircraft since 2004, and Federal Aviation Administration regulations require that AEDs be properly labeled, regularly inspected for readiness to perform during emergencies and function properly according to their manufacturer's recommendations.

The case is _Melissa Suzette Arzu, Individually and as the Administrator of the Estate of Kevin Greenidge, Deceased v. American Airlines, Inc.,_ Case No. 4:24-cv-00433-P, filed in the U.S. District Court for the Northern District of Texas, Fort Worth Division.

**Media Contact:**  
Fabian Gutierrez  
fabian@androvett.com  
800-559-4534

View source version on businesswire.com: https://www.businesswire.com/news/home/20260518839012/en/

### Related Stocks

- [AAL.US](https://longbridge.com/en/quote/AAL.US.md)
- [AALG.US](https://longbridge.com/en/quote/AALG.US.md)

## Related News & Research

- [FACTBOX-Airlines tackle fuel cost surge with price hikes, outlook cuts](https://longbridge.com/en/news/286262796.md)
- [Delta is canceling hundreds of flights due to crew and scheduling challenges, an internal memo shows](https://longbridge.com/en/news/285123971.md)
- [AIRBUS > TARGETS WIDESPREAD 10% COST CUTS IN PLANEMAKING UNIT AND GROUP HQ, SOURCES SAY](https://longbridge.com/en/news/286919245.md)
- [Supreme Court rejects drugmakers’ bid to halt Medicare price talks](https://longbridge.com/en/news/286922283.md)
- [Sanofi says rare lung disease drug outperforms standard care in trial](https://longbridge.com/en/news/286810610.md)